Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $3.8 million.

  • Phibro Animal Health's Deferred Taxes rose 14958.66% to $3.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.8 million, marking a year-over-year increase of 17573.65%. This contributed to the annual value of -$4.9 million for FY2025, which is 5948.35% up from last year.
  • Per Phibro Animal Health's latest filing, its Deferred Taxes stood at $3.8 million for Q4 2025, which was up 14958.66% from $2.2 million recorded in Q3 2025.
  • Phibro Animal Health's Deferred Taxes' 5-year high stood at $8.4 million during Q2 2025, with a 5-year trough of -$7.7 million in Q4 2024.
  • Moreover, its 5-year median value for Deferred Taxes was -$403000.0 (2021), whereas its average is -$826900.0.
  • Its Deferred Taxes has fluctuated over the past 5 years, first plummeted by 2060000.0% in 2023, then surged by 25970.21% in 2025.
  • Phibro Animal Health's Deferred Taxes (Quarter) stood at -$506000.0 in 2021, then surged by 78.66% to -$108000.0 in 2022, then tumbled by 3432.41% to -$3.8 million in 2023, then tumbled by 102.88% to -$7.7 million in 2024, then soared by 149.59% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q4 2025, $2.2 million for Q3 2025, and $8.4 million during Q2 2025.